期刊文献+

复方羟甲唑啉鼻用凝胶的制备及质量控制 被引量:2

下载PDF
导出
摘要 目的:制备复方羟甲唑啉鼻用凝胶,并建立其质量控制方法。方法:以盐酸羟甲唑啉与富马酸酮替芬为主要成分,羧甲基纤维素钠为凝胶基质,制备复方羟甲唑啉鼻用凝胶;采用高效液相色谱法同时测定盐酸羟甲唑啉、富马酸酮替芬的含量。结果:该制剂pH及其他检查均符合鼻用凝胶的相关规定,盐酸羟甲唑啉,富马酸酮替芬分别在25~150mg.L-1,75~450mg.L-1范围内,峰面积与其质量浓度线性关系良好,平均回收率分别为100.1%,99.93%;RSD为1.36%,1.34%。结论:该制剂制备工艺简单,质量可控。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第8期1163-1164,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献4

二级参考文献13

  • 1[1]Koh Y Y.Allergic rhinitis.Med Prog,1996,26:23-29.
  • 2[2]Pitkaranta A,Wecker M T,Korts D C,et al.Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.Am J Rhinol,1998,12:125-129.
  • 3[3]Hochban W,Althoff H,Ziegler A.Nasal decongestion with imidazoline derivatives:Acoustic rhinometry measurements.Eur J Clin Pharmacol,1999,55:7-12.
  • 4[4]Ferguson B J,Paramaesvaran S,Rubinstein E.A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.Otolaryngol Head Neck Surg,2001,125:253-260.
  • 5[5]Jawad S S,Eccles R.Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold.Rhinology,1998,36:73-76.
  • 6[6]Jones J S,Sheffield W,White L J,et al.A double-blind comparison between oral pseudoephedrine and topical oxymetazoline in the prevention of barotrauma during air travel.Am J Emerg Med, 1998,16:262-264.
  • 7[7]Mazzotta P,Loebstein R,Koren G.Treating allergic rhinitis in pregnancy:Safety considerations. Drug Saf,1999,20:361-375.
  • 8丁玉峰,王新桃,曾勤.替硝唑凝胶的研制[J].中国医院药学杂志,1999,19(7):402-404. 被引量:16
  • 9王岩,陈有钟,李善子,苏德森.特非那定凝胶滴鼻剂的研制[J].中国药学杂志,1999,34(6):386-388. 被引量:2
  • 10马树人,钟天耕,于筛成,张琳,钱速越.丹参酮凝胶剂的释药性研究[J].中成药,1999,21(12):617-619. 被引量:31

共引文献117

同被引文献12

  • 1Xuan B, Chiou GCY. Efficacy of oxymetazoline eye drops in non-infectious conjunctivitis,the most common cause of acute red eyes[J].J Ocul Phamacol Ther,1997,13(4):363- 367.
  • 2Tirnaksiz F, Robinson JR. Rheological, mucoadhesive and release properties of pluronic F- 127 gel and pluronic F- 127/ polycarbophil mixed gel systems [J]. Pharmazie,2005,60 (7):518-523.
  • 3Choi HG,Jung JH,Ryu JM,et al. Development of in situgelling and mucoadhesive acetaminophen liquid suppository [J]. Int J Pharm,1998,165(1):33-34.
  • 4Zhao YZ, Li X, Lu CT, et al. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy[J]. Acta Diabetol, 2011,Nov 29.[Epub ahead of print].
  • 5Xuan B, Chiou GC. Efficacy of oxymetazoline eye drops in non-infectious conjunctivitis, the most common cause of acute red eyes[J]. J Ocul Pharmacol Ther, 1997, 13 (4) : 363.
  • 6毕殿洲筠剂学[M].北京:人民卫生出版社,2002:279.
  • 7E1-Kamel AH. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate[J]. lnt JPharm, 2002,241 ( 1 ) : 47.
  • 8李素霞,曹德英,王刚.眼用即型凝胶的研究进展[J].中国医院药学杂志,2008,28(3):228-230. 被引量:16
  • 9杨艺红.HPLC法测定盐酸羟甲唑啉喷雾剂的含量[J].海峡药学,2009,21(9):31-33. 被引量:4
  • 10姜芳宁,刘效栓,刘光斌.甲磺酸帕珠沙星眼用即型凝胶的制备及质量控制[J].中国实用医药,2010,5(11):14-15. 被引量:2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部